Stoke Therapeutics, Inc. (STOK) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Stoke Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Stoke Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $6.06 M, a 44.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6.06 M +$1.86 M +44.2% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $6.61 M +$1.86 M +39.1% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 $3.08 M -$2.21 M -41.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.65 M -$2.19 M -37.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.2 M -$361 K -7.91% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.75 M -$186 K -3.77% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $5.3 M -$31 K -0.58% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.83 M +$4.57 M +364% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $4.56 M +$3.72 M +441% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.94 M +$3.82 M +343% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $5.33 M +$3.95 M +286% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.26 M -$384 K -23.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $844 K -$1.06 M -55.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.12 M Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.38 M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.64 M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.9 M Mar 31, 2020 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.